Conferences

Genoskin at the EUROTOX 2026 Congress

Advancing drug development with New Approach Methodologies (NAMs)

Genoskin is pleased to announce its participation as an exhibitor (booth #51) in the EUROTOX 2026 Congress to be held from September 13th to 16th at the Austria Center Vienna (ACV), Vienna (Austria).

Organised by the Austrian Society of Toxicology, EUROTOX is celebrating its 60th Congress in Vienna and will embrace the theme “Toxicology without borders”—creating a unique forum for scientific exchange, new perspectives, and collaborations shaping the future of toxicology.

Meet Genoskin at EUROTOX 2026

Genoskin will be there to advance the conversation around more human-relevant toxicology assessment.

As the industry continues to move toward New Approach Methodologies (NAMs), access to predictive human data earlier in development is becoming increasingly important.

We will also present a scientific poster highlighting our latest research and applications of human ex vivo skin models.

Scientific poster presentation

Improving Clinical Translation Through Human Skin-Based New Approach Methodologies

Adeline Chaubet, Mathias Peries, Mamoudou Daillo, Laurianne Kandalaft, Anthony David, Emeline Pages, Nicolas Gaudenzio

This poster highlights how human skin-based NAMs can provide biologically relevant insights to support more predictive and clinically translatable drug development.

E-Poster

Let’s connect in Vienna

📍 Vienna, Austria – Austria Center Vienna (ACV)
📅 September 13–16, 2026

Meet the Genoskin team at EUROTOX 2026 and discover how ex vivo human skin can strengthen your toxicology strategy with biologically relevant human data.

Planning to attend? Let us know you're coming.

Want more research like this in your inbox? Subscribe to our newsletter →

Comments are closed.